Earnings call transcript: Kingstone Q4 2025 EPS beats forecast, revenue misses

Kingstone reported Q4 EPS of $1.03 vs $0.56 consensus (an 83.93% beat) while revenue missed at $56.42M vs $82.7M (‑31.78%); Q4 net income was $14.8M and FY2025 net income $40.8M. Management touted strong metrics — Q4 ROE 51% (FY ROE 43%), book value per share $8.28 (+75% YoY), expense ratio 30% — and issued FY2026 guidance of diluted EPS $2.20–$2.90 (mid $2.55) with revenue targets (~$222.4M) and an assumed CAT load of 7–10 pts driving a net combined ratio of 81%–86%. Market reacted negatively to the revenue miss (stock down 5.58% after-hours to $15.58, later trading at $14.74) while the company announced a disciplined California E&S expansion in Q2 2026 (initial contribution <5% of 2026 premium, 30% quota share) and declared a third consecutive quarterly dividend.

Analysis

Market attention will cluster on headline revenue variance, but the more durable driver of shareholder returns is the shift in risk retention and operating leverage — management is now a larger direct residual claimant on underwriting performance. That makes profitability more sensitive to claim frequency and catastrophe volatility (not just pricing), and increases earnings convexity to underwriting improvements; conversely, it amplifies downside from an adverse claims year.

Entering California on an E&S basis is strategically smart from a margin and pricing-flexibility perspective, but it trades scaled premium growth for model and accumulation risk. Early-stage E&S entries typically show attractive unit economics while the book is small, then reveal model drift and clustering of tail exposures as scale rises; the 12–36 month horizon is where miscalibration shows up and where reinsurance program design matters most.

Two underappreciated levers will drive next moves: investment income reinvestment and regulatory posture. With more float retained on the balance sheet, higher new-money yields materially lift net investment contribution but also increase interest-rate and duration management responsibilities. Regulatory or affordability interventions in core states and any surprise reserve development remain asymmetric downside catalysts that could compress multiples faster than growth can re-rate them.

Key Decisions for Investors

• Long KINS equity (3–12 month horizon): Initiate a modest position to play a re-rating as underwriting leverage normalizes and Select penetration scales. Size at 1–2% portfolio, use a 15–20% stop to limit drawdown if reserve development or catastrophe frequency reverses the thesis.
• Call-spread (12–18 months) to express upside with limited capital: Buy a near-term-to-intermediate call spread on KINS to capture re-rating while capping premium spent; roll higher if Q2 shows disciplined, profitable CA entry and stable reserve trends. This reduces theta bleed versus naked calls.
• Paired trade to isolate underwriting alpha (6–12 months): Long KINS / short a diversified regional P&C basket to hedge market and rate moves and isolate improvements from Select product and quota-share reductions. Use the pair to monetize relative outperformance if frequency declines continue.
• Event hedges ahead of weather seasons and reinsurance renewals (days–months): Reduce gross exposure or purchase downside protection (OTM puts or protective collars) into hurricane/winter storm seasons and before primary reinsurance treaty renewals or any NY regulatory milestones to limit tail losses.